Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,248.00
-40.65 (-1.78%)
At close: Sep 16, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 941.84 billion as of September 16, 2026. Its market cap has decreased by -11.74% in one year.
Market Cap
941.84B
Enterprise Value
985.48B
Revenue
147.38B
Ranking
n/a
PE Ratio
46.11
Stock Price
2,248.00
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 941.84B, an increase of 65.31%. That is a compound annual growth rate of 16.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 941.84B | 3.87% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.89T |
| Dr. Reddy's Laboratories | 967.09B |
| Lupin | 958.36B |
| Abbott India | 543.69B |
| GlaxoSmithKline Pharmaceuticals | 480.64B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |